Long-term carcinogenicity of cyclophosphamide in two mouse strains with different spontaneous leukemia incidence
References (18)
- et al.
Genetic/epidemiological findings in a study of smoking-associated tumors
Cancer Genet. Cytogenet.
(1982) - et al.
Occurrence of second tumors in man after anticancer drug treatment
Cancer Treat. Rev.
(1982) - et al.
Treatment of spontaneous leukemia in AKR mice with chemotherapy, immunotherapy, or interferon
Cancer Res.
(1976) Multiple comparison using rank sums
Technometrics
(1964)“Spontaneous” leukemia developing in C3H mice following inoculation, in infancy, with AK-leukemic extracts or AK embryos
Genetic predisposition for cancer risks in man
- et al.
Potentiation of anticancer agents by amphotericin B
J. Natl. Cancer Inst.
(1981) - et al.
Guidelines for simple, sensitive significance tests for carcinogenic effects in long-term animal experiments
There are more references available in the full text version of this article.
Cited by (5)
Risk of subsequent non-germ cell cancer after treatment of germ cell cancer in 2006 Norwegian male patients
1997, European Journal of Cancer Part ASurvey of tumorigenic sensitivity in 6-month rasH2-Tg mice studies compared with 2-year rodent assays
2022, Journal of Toxicologic PathologyCyclophosphamide
2011, IARC Monographs on the Evaluation of Carcinogenic Risks to HumansInvited review: Critical review of preclinical approaches to evaluate the potential of immunosuppressive drugs to influence human neoplasia
2010, International Journal of ToxicologyFormaldehyde as a potential human leukemogen: An assessment of biological plausibility
2006, Critical Reviews in Toxicology
Copyright © 1989 Published by Elsevier Ireland Ltd.